COMMUNIQUÉS West-GlobeNewswire

-
Apellis Pharmaceuticals to Host Conference Call on February 28, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
14/02/2025 - 13:00 -
Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
14/02/2025 - 13:00 -
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
14/02/2025 - 13:30 -
Theratechnologies annoncera ses résultats financiers du quatrième trimestre et de l’exercice 2024 et fera une mise à jour de ses activités
14/02/2025 - 13:30 -
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
14/02/2025 - 13:30 -
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025
14/02/2025 - 13:30 -
Enlitic, Inc. to Showcase AI Enabled Workflows at ViVE 2025
14/02/2025 - 13:42 -
PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products
14/02/2025 - 14:00 -
Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment
14/02/2025 - 14:00 -
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference
14/02/2025 - 14:00 -
ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences
14/02/2025 - 14:00 -
Extendicare Announces February 2025 Dividend of C$0.04 per Share
14/02/2025 - 14:00 -
Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination
14/02/2025 - 14:00 -
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update
14/02/2025 - 14:05 -
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
14/02/2025 - 14:10 -
Sienna Announces February Dividend
14/02/2025 - 14:30 -
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
14/02/2025 - 14:45 -
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®
14/02/2025 - 15:00 -
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
14/02/2025 - 15:00
Pages